钆塞酸二钠增强T1弛豫测量评估实时13C-美沙西汀呼气试验测定的肝功能
研究纳入66例患者,在3T行钆塞酸二钠增强T1弛豫测量并同日行13C-美沙西汀呼气试验评估肝功能。按呼气试验结果分三类后,随肝功能减退T1post持续升高(p≤0.030),ΔR1与rrT1持续降低(分别p≤0.025、p<0.018);13C-MBT值与T1post、ΔR1、rrT1呈对数线性相关(r分别为0.57、0.59、0.70,均p<0.001),作者认为可由MR弛豫测量定量估算肝功能。
要点
- 肝功能减退进展时,增强后T1post持续升高(p≤0.030),ΔR1与rrT1持续降低。
- 13C-MBT值与rrT1相关性最强(r=0.70,p<0.001),其次为ΔR1(r=0.59)和T1post(r=0.57)。
- 所有T1弛豫值与指数的观察者间信度ICC均>0.88。
核心结论
- 实时13C-美沙西汀呼气试验测定的肝功能可由钆塞酸二钠增强MR弛豫测量定量估算。
研究设计与样本
- 单中心研究,66例患者接受13C-美沙西汀呼气试验评估肝功能,并在3T行钆塞酸二钠增强T1弛豫测量。
- 采用横断面3D VIBE序列,基于可变翻转角在线计算T1,于增强前(T1pre)及注射钆塞酸二钠后20分钟(T1post)采集。
- 评估增强前后T1弛豫时间下降率(rrT1)与T1弛豫速率指数(ΔR1),并与13C-MBT值相关分析,建立基于MRI的13C-MBT估算值。
关键影像表现/征象
- 按13C-MBT读数分为三类后,随肝功能减退进展,T1post持续升高(p≤0.030)。
- 随13C-MBT评估的肝损伤进展,ΔR1持续显著降低(p≤0.025),rrT1持续显著降低(p<0.018)。
诊断标准与关键数值
- 简单回归模型显示13C-MBT值与T1post呈对数线性相关(r=0.57;p<0.001)。
- 13C-MBT值与ΔR1呈对数线性相关(r=0.59;p<0.001),与rrT1呈对数线性相关(r=0.70;p<0.001)。
- 所有T1弛豫值与指数的观察者间信度ICC均>0.88。
临床应用与阅片要点
- 作者认为钆塞酸二钠增强MR弛豫测量可能为术前评估肝功能提供参数。
- 作者认为钆塞酸二钠增强MR弛豫测量可能有助于监测肝病进展。
- 作者认为钆塞酸二钠增强MR弛豫测量有潜力成为新的肝功能指标。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVES: To determine whether liver function as determined by intravenous administration of 13C-methacetin and continuous real-time breath analysis can be estimated quantitatively from gadoxetic acid (Gd-EOB-DTPA)-enhanced magnetic resonance (MR) relaxometry.
METHODS: Sixty-six patients underwent a 13C-methacetin breath test (13C-MBT) for evaluation of liver function and Gd-EOB-DTPA-enhanced T1-relaxometry at 3 T. A transverse 3D VIBE sequence with an inline T1 calculation based on variable flip angles was acquired prior to (T1 pre) and 20 min post-Gd-EOB-DTPA (T1 post) administration. The reduction rate of T1 relaxation time (rrT1) and T1 relaxation velocity index (∆R1) between pre- and post-contrast images was evaluated. 13C-MBT values were correlated with T1post, ∆R1 and rrT1, providing an MRI-based estimated 13C-MBT value. The interobserver reliability was assessed by determining the intraclass correlation coefficient (ICC).
RESULTS: Stratified by three different categories of 13C-MBT readouts, there was a constant increase of T1 post with increasing progression of diminished liver function (p ≤ 0.030) and a constant significant decrease of ∆R1 (p ≤ 0.025) and rrT1 (p < 0.018) with progression of liver damage as assessed by 13C-methacetin breath analysis. ICC for all T1 relaxation values and indices was excellent (> 0.88). A simple regression model showed a log-linear correlation of 13C-MBT values with T1post (r = 0.57; p < 0.001), ∆R1 (r = 0.59; p < 0.001) and rrT1 (r = 0.70; p < 0.001).
CONCLUSION: Liver function as determined using real-time 13C-methacetin breath analysis can be estimated quantitatively from Gd-EOB-DTPA-enhanced MR relaxometry.
KEY POINTS: • Gd-EOB-DTPA-enhanced T1 relaxometry quantifies liver function • Gd-EOB-DTPA-enhanced MR relaxometry may provide parameters for assessing liver function before surgery • Gd-EOB-DTPA-enhanced MR relaxometry may be useful for monitoring liver disease progression • Gd-EOB-DTPA-enhanced MR relaxometry has the potential to become a novel liver function index.
引用
- Haimerl M, Fuhrmann I, Poelsterl S, et al. Gd-EOB-DTPA-enhanced T1 relaxometry for assessment of liver function determined by real-time 13C-methacetin breath test. Eur Radiol. 2018. PMID: 29532241. doi:10.1007/s00330-018-5337-y
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。